Tag: Eli Lilly
Business & Industry
Lilly Signs $1.26bn Sonefpeglutide Licensing Deal with Hanmi
Eli Lilly and Company and Hanmi Pharm have officially finalized a comprehensive licensing agreement. Under the terms of the worldwide arrangement, Sonefpeglutide licensing is...
Business & Industry
Eli Lilly Returns to Infectious Disease with $3.8 Billion Acquisition Strategy
After a seven-year absence from the sector, Eli Lilly is returning to the field through a trio of corporate purchases valued at more than...
Business & Industry
Eli Lilly Kelonia Acquisition Advances in $2B Deal Talks
Eli Lilly and Company is in advanced discussions to acquire Kelonia Therapeutics for more than $2 billion, according to a report by The Wall...
Business & Industry
Eli Lilly to Acquire Centessa Pharmaceuticals in $7.8B Deal
Eli Lilly & Co. is set to acquire Centessa Pharmaceuticals Plc in a transaction worth up to $7.8 billion, underscoring its push to broaden...
Business & Industry
Lilly, Insilico Sign $2.75B AI Drug Discovery Collaboration
Eli Lilly has expanded its engagement with Insilico Medicine, formalising a new AI drug discovery collaboration valued at up to $2.75 billion, further extending...
Business & Industry
Lilly Launches New AI Supercomputer for Drug Development
Eli Lilly has launched what it describes as the most powerful AI factory wholly owned and operated by a pharmaceutical company, marking a significant...
Clinical Trials
Lilly Zepbound-Taltz Combo Gains Ground with Phase 3b Data
Eli Lilly said that its weight-loss medicine Zepbound, when used in combination with psoriasis treatment Taltz, delivered stronger outcomes than Taltz alone in patients...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read